<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./10_1101_780577v1/results/search/disease/results.xml">
  <result pre="endosomal compartment. Pseudotyping retroviruses with particular glycoproteins, e.g., the vesicular" exact="stomatitis" post="glycoprotein (VSV G), renders the infectivity of particles resistant"/>
  <result pre="Orthomyxovirus genera. Infectivity of particles, pseudotyped with HIV-1, amphotropic-MLV, or" exact="influenza" post="virus glycoproteins, was decreased by SERINC5, whether the core"/>
  <result pre="virus-A, human endogenous retrovirus K (HERV-K), ecotropic-MLV, HTLV-1, Measles morbillivirus," exact="lymphocytic choriomeningitis" post="mammarenavirus (LCMV), Marburg virus, Ebola virus, severe acute respiratory"/>
  <result pre="to SERINC5. In contrast, particles pseudotyped with M-PMV, RD114, or" exact="rabies" post="virus (RABV) glycoproteins were sensitive to SERINC5, but only"/>
  <result pre="One of these retroviruses causes tumors in mice, a second" exact="anemia" post="in horses, and a third causes AIDS. SERINC5 is"/>
  <result pre="encoded proteins are found outside of primate immunodeficiency viruses. Murine" exact="leukemia" post="virus (MLV) Glycogag and equine infectious anemia virus (EIAV)"/>
  <result pre="immunodeficiency viruses. Murine leukemia virus (MLV) Glycogag and equine infectious" exact="anemia" post="virus (EIAV) S2 are viral antagonists of SERINC5 activity,"/>
  <result pre="membrane ( 19, 25). Importantly, HIV-1 particles pseudotyped with vesicular" exact="stomatitis" post="virus (VSV) G or Ebola virus glycoprotein are resistant"/>
  <result pre="antiviral effects of SERINC5, the glycoproteins from NL4.3, A-MLV, and" exact="influenza" post="were inhibited by SERINC5 in all viral core pseudotypes"/>
  <result pre="that sensitivity to SERINC5 antiviral activity for M-PMV, RD114, and" exact="rabies" post="virus (RABV) glycoproteins depended on the retroviral core onto"/>
  <result pre="RD114, Mason-Pfizer monkey virus (M-PMV), ecotropic MLV (EcoMLV), amphotropic murine" exact="leukemia" post="virus (A-MLV), and human T-cell lymphoma virus-1 (HTLV-1). We"/>
  <result pre="MLV (EcoMLV), amphotropic murine leukemia virus (A-MLV), and human T-cell" exact="lymphoma" post="virus-1 (HTLV-1). We also tested the glycoproteins from an"/>
  <result pre="tested the glycoproteins from an assortment of RNA viruses including" exact="influenza" post="(H7/N1), parainfluenza 5 (PIV5), measles, rabies virus (RABV), lymphocytic"/>
  <result pre="of RNA viruses including influenza (H7/N1), parainfluenza 5 (PIV5), measles," exact="rabies" post="virus (RABV), lymphocytic choriomeningitis virus (LCMV), Marburg virus (MARV),"/>
  <result pre="including influenza (H7/N1), parainfluenza 5 (PIV5), measles, rabies virus (RABV)," exact="lymphocytic choriomeningitis" post="virus (LCMV), Marburg virus (MARV), Ebola virus Zaire [Mayinga]"/>
  <result pre="(EBOV), severe acute respiratory virus coronavirus (SARS CoV), and vesicular" exact="stomatitis" post="virus (VSV). For these experiments we considered glycoprotein pseudotypes"/>
  <result pre="1). Interestingly, we observed &amp;gt;;10-fold reduction of infectivity of H7/N1" exact="influenza" post="and RABV pseudotypes. No other pseudotypes displayed &amp;gt;;10-fold reduced"/>
  <result pre="how the viral glycoprotein mediates fusion, as fusion mediated by" exact="influenza" post="( 27) or by RABV ( 28) occurs in"/>
  <result pre="MLV, AMLV: amphotropic MLV, HTLV-1: human T-cell lymphotropic virus-1, Flu:" exact="influenza" post="type A, PIV5: parainfluenza virus 5, RABV: rabies virus,"/>
  <result pre="virus-1, Flu: influenza type A, PIV5: parainfluenza virus 5, RABV:" exact="rabies" post="virus, LCMV: Lymphocytic choriomeningitis virus, MARV: Marburg virus, EBOV:"/>
  <result pre="Marburg virus, EBOV: Mayinga isolate of Zaire ebolavirus, SARS CoV:" exact="severe acute respiratory syndrome" post="coronavirus, VSV: vesicular stomatitis virus, LLOV: Lloviu virus, RESTV:"/>
  <result pre="ebolavirus, SARS CoV: severe acute respiratory syndrome coronavirus, VSV: vesicular" exact="stomatitis" post="virus, LLOV: Lloviu virus, RESTV: Reston virus, SUDV: Sudan"/>
  <result pre="MLV, AMLV: amphotropic MLV, HTLV-1: human T-cell lymphotropic virus-1, Flu:" exact="influenza" post="type A, PIV5: parainfluenza virus 5, RABV: rabies virus,"/>
  <result pre="virus-1, Flu: influenza type A, PIV5: parainfluenza virus 5, RABV:" exact="rabies" post="virus, LCMV: Lymphocytic choriomeningitis virus, MARV: Marburg virus, EBOV:"/>
  <result pre="Marburg virus, EBOV: Mayinga isolate of Zaire ebolavirus, SARS CoV:" exact="severe acute respiratory syndrome" post="coronavirus, VSV: vesicular stomatitis virus, LLOV: Lloviu virus, RESTV:"/>
  <result pre="ebolavirus, SARS CoV: severe acute respiratory syndrome coronavirus, VSV: vesicular" exact="stomatitis" post="virus, LLOV: Lloviu virus, RESTV: Reston virus, SUDV: Sudan"/>
  <result pre="with RD114 (∼20-fold) surpassed our 10-fold cutoff for significance. Conversely," exact="rabies" post="virus (RABV) glycoprotein pseudotypes of M-PMV were unaffected by"/>
  <result pre="with glycoproteins from several retroviruses (HIV-1, A-MLV, RD114, and M-PMV)," exact="influenza" post="A (Orthomyxoviridae), and rabies (Rhabdoviridae). To our knowledge, this"/>
  <result pre="retroviruses (HIV-1, A-MLV, RD114, and M-PMV), influenza A (Orthomyxoviridae), and" exact="rabies" post="(Rhabdoviridae). To our knowledge, this is the first time"/>
  <result pre="it remains to be established if the infectivity of authentic" exact="influenza" post="or rabies viruses are affected by SERINC5, or other"/>
  <result pre="to be established if the infectivity of authentic influenza or" exact="rabies" post="viruses are affected by SERINC5, or other SERINC family"/>
  <result pre="SERINC5, or other SERINC family members. Additionally, our observation with" exact="influenza" post="A and rabies glycoproteins demonstrates that mediating entry via"/>
  <result pre="SERINC family members. Additionally, our observation with influenza A and" exact="rabies" post="glycoproteins demonstrates that mediating entry via an endocytic route"/>
  <result pre="the viral core onto which they were pseudotyped. For instance," exact="rabies" post="virus glycoprotein was inhibited by SERINC5 when on HIV-1"/>
  <result pre="here, for which SERINC5 restriction activity was core-dependent, i.e., the" exact="rabies" post="virus, MPMV, and RD114 glycoproteins. MATERIALS AND METHODS Plasmid"/>
  <result pre="Carpenter S , Pizzato M. 2016. S2 from equine infectious" exact="anemia" post="virus is an infectivity factor which counteracts the retroviral"/>
  <result pre="Henneberry J , White J , Helenius A. 1986. Variant" exact="influenza" post="virus hemagglutinin that induces fusion at elevated pH. J"/>
  <result pre=", Kirchhausen T , Whelan SPJ . 2013. Uptake of" exact="rabies" post="virus into epithelial cells by clathrin-mediated endocytosis depends upon"/>
  <result pre="Cloyd M. 1983. Characterization of monoclonal antibodies reactive with murine" exact="leukemia" post="viruses: use in analysis of strains of friend MCF"/>
  <result pre="analysis of strains of friend MCF and Friend ecotropic murine" exact="leukemia" post="virus. Virology 127: 134– 148. OpenUrl CrossRef PubMed Web"/>
  <result pre=", Buchmeier MJ . 2007. Mapping the landscape of the" exact="lymphocytic choriomeningitis" post="virus stable signal peptide reveals novel functional domains. J"/>
  <result pre="Itamura S , Kurane I , Morikawa S. 2005. Vesicular" exact="stomatitis" post="virus pseudotyped with severe acute respiratory syndrome coronavirus spike"/>
  <result pre="I , Morikawa S. 2005. Vesicular stomatitis virus pseudotyped with" exact="severe acute respiratory syndrome" post="coronavirus spike protein. J Gen Virol 86: 2269– 2274."/>
  <result pre="Russell SJ , Cosset FL . 1998. Incorporation of fowl" exact="plague" post="virus hemagglutinin into murine leukemia virus particles and analysis"/>
  <result pre=". 1998. Incorporation of fowl plague virus hemagglutinin into murine" exact="leukemia" post="virus particles and analysis of the infectivity of the"/>
  <result pre=", Olsen JC . 2006. Influenza M2 envelope protein augments" exact="avian influenza" post="hemagglutinin pseudotyping of lentiviral vectors. Gene Ther 13: 715–"/>
  <result pre="Olsen JC . 2006. Influenza M2 envelope protein augments avian" exact="influenza" post="hemagglutinin pseudotyping of lentiviral vectors. Gene Ther 13: 715–"/>
  <result pre="Maisner A. 2002. Importance of the cytoplasmic tails of the" exact="measles" post="virus glycoproteins for fusogenic activity and the generation of"/>
  <result pre="virus glycoproteins for fusogenic activity and the generation of recombinant" exact="measles" post="viruses. J Virol 76: 7174– 7186. OpenUrl Abstract /"/>
 </snippets>
</snippetsTree>
